Kai Ye Selected Research

Diplopia (Double Vision)

1/2023

Rapamycin improves Graves' orbitopathy by suppressing CD4+ cytotoxic T lymphocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kai Ye Research Topics

Disease

29	Neoplasms (Cancer) 04/2024 - 03/2003
7	Colonic Neoplasms (Colon Cancer) 04/2024 - 01/2018
6	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2020
6	Breast Neoplasms (Breast Cancer) 03/2023 - 01/2017
5	Stomach Neoplasms (Stomach Cancer) 01/2024 - 10/2018
4	Adenocarcinoma 02/2024 - 01/2020
4	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 06/2016
4	Rectal Neoplasms (Rectal Cancer) 01/2023 - 11/2022
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 04/2024 - 04/2014
3	Hepatocellular Carcinoma (Hepatoma) 03/2023 - 07/2019
3	Hepatitis B 03/2023 - 11/2018
3	Melanoma (Melanoma, Malignant) 01/2023 - 01/2019
3	Microsatellite Instability 01/2020 - 04/2014
3	Carcinogenesis 01/2020 - 02/2019
2	Hemorrhage 01/2024 - 01/2018
2	Fibrosis (Cirrhosis) 01/2023 - 07/2019
2	Infections 12/2021 - 09/2004
2	Lymphatic Metastasis 12/2019 - 01/2018
2	Body Weight (Weight, Body) 02/2019 - 02/2019
1	Tissue Adhesions 03/2024
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024
1	Flatulence 01/2024
1	Pneumonia (Pneumonitis) 01/2024
1	Bile Reflux 11/2023
1	Extranodal Extension 10/2023
1	Confusion (Bewilderment) 01/2023
1	Diplopia (Double Vision) 01/2023
1	Abdominal Hernia (Abdominal Hernias) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Graves Ophthalmopathy 01/2023
1	Signet Ring Cell Carcinoma 12/2022
1	Chylous Ascites 09/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Cholangiocarcinoma 01/2022
1	Constipation 04/2021
1	Atrophy 02/2021

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 03/2023 - 03/2003
6	RNA (Ribonucleic Acid)IBA 03/2023 - 01/2020
4	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 09/2004
3	Transcription Factors (Transcription Factor)IBA 04/2024 - 11/2018
3	Oncogene Proteins (Oncogene Protein)IBA 03/2023 - 11/2018
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2013
2	camrelizumabIBA 02/2024 - 01/2024
2	Immunoglobulin A (IgA)IBA 10/2023 - 01/2022
2	CollagenIBA 01/2023 - 07/2019
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2023 - 01/2023
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2022 - 07/2019
2	Indicators and Reagents (Reagents)IBA 12/2019 - 04/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2024
1	Immune Checkpoint InhibitorsIBA 04/2024
1	Liposomes (Liposome)IBA 04/2024
1	GraphiteIBA 04/2024
1	Cytotoxins (Cytolysins)IBA 04/2024
1	Carbon Tetrachloride (Tetrachloromethane)IBA 02/2024
1	HMGB1 Protein (HMG1)IBA 02/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024
1	Carcinoembryonic AntigenIBA 01/2024
1	SolutionsIBA 01/2024
1	130-nm albumin-bound paclitaxelIBA 01/2024
1	apatinibIBA 01/2024
1	Angiogenesis InhibitorsIBA 01/2024
1	Tumor Biomarkers (Tumor Markers)IBA 12/2023
1	tyramine-deoxysorbitolIBA 10/2023
1	BezafibrateIBA 03/2023
1	ActomyosinIBA 03/2023
1	Phosphotransferases (Kinase)IBA 03/2023
1	Sorafenib (BAY 43-9006)FDA Link 03/2023
1	Nonmuscle Myosin Type IIAIBA 03/2023
1	SteroidsIBA 01/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	gelatin methacryloylIBA 01/2023
1	Interleukin-12 (IL 12)IBA 12/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	CationsIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	VaccinesIBA 01/2022
1	CytokinesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	TubulinIBA 02/2021
1	pyrrolineIBA 01/2021

Therapy/Procedure

10	Therapeutics 02/2024 - 11/2011
6	Gastrectomy 01/2024 - 10/2018
6	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 01/2018
4	Colectomy 12/2022 - 01/2018
4	Immunotherapy 01/2022 - 01/2020
3	Neoadjuvant Therapy 02/2024 - 11/2022
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2023
1	Combination Drug Therapy (Combination Chemotherapy) 04/2024
1	Quantum Dots (Quantum Dot) 04/2024
1	Transplantation 03/2024
1	Ligation 02/2024
1	Length of Stay 01/2024
1	Gastroenterostomy 11/2023
1	Pelvic Exenteration 11/2022
1	Chemoradiotherapy 04/2021